Thyroxine prophylaxis after bilateral subtotal thyroidectomy for multinodular goiter

Endocrine Journal

Volumn 47, Issue 3, 2000, Pages 349-352

  Kulaçoglu, Hakan ^a,c   Dener, Cenap ^b   Ziraman, Ipek ^a   Kama, Nuri A ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b FATIH UNIVERSITY MEDICAL SCHOOL   (Turkey)

^c Bahcelievler   (Turkey)

Author keywords

Endemic region; Multinodular goiter; Recurrence; Thyroidectomy; Thyroxine

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE;

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDEMIC DISEASE; FEMALE; FOLLOW UP; HUMAN; HYPOPHYSIS THYROID SYSTEM; HYPOTHYROIDISM; MALE; NODULAR GOITER; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SUBTOTAL THYROIDECTOMY; THYROTROPIN BLOOD LEVEL; TURKEY (REPUBLIC);

EID: 0343628896     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.47.349     Document Type: Article

References (15)

1. Gaitan E, Nelson N, Poole GV (1991) Endemic goiter and endemic thyroid disorders. World J Surg 15: 205-215.
2. Calik A, Kucuktulu U, Cinel A, Bilgin Y, Alhan E, Piskin B (1996) Complications of 867 thyroidectomies performed in a region of endemic goiter in Turkey. Int Surg 81: 298-301.
3. WHO/UNICEF/ICCIDD (1993) Global prevalence of iodine deficiency disorders. Geneva: World Health Organization.
4. Ibis E, Erbay G, Aras G, Akin A (1990) Postoperative goiter recurence rate in Turkey. Acta Endocrinol 125: 33-37.
5. Calik A, Kucuktulu U, Bilgin Y, Cinel A, Alhan E, Piskin B (1999) Prevention of recurrences after thyroidectomy in an endemic area with prophylactic levothyroxine use. Tr J Medical Sciences 29: 273-277.
6. Querido A (1974) Definitions of endemic goiter and cretinism, classification of goiter size and severity of endemias, and survey techniques. In: Dunn JT, Mederioc-Neto GA (eds) Endemic Goiter and Cretinism: Continuing Threats to World Health. World Health Organization, Washington DC, Pub. No. 292.
7. Berglund J, Bondesson L, Christensen SB, Larsson AL, Tibblin S (1994) Indications for thyroxine therapy after surgery for nontoxic benign goiter. Acta Chir Scand 156: 433-438.
8. Bistrup C, Nielsen JD, Gregersen G, Franch P (1994) Preventive effect of levothyroxine in patients operated for non-toxic goiter: a randomized trial of one hundred patients with nine years follow-up. Clin Endocrinol 40: 323-327.
9. Röjdmark J, Järhult J (1995) High long term recurrence rate after subtotal thyroidectomy for nodular goiter. Eur J Surg 161: 725-727.
10. Hegedüs L, Nygaard B, Hansen JM (1999) Is routine thyroxine treayment to hinder postoperative recurrence of nontoxic goiter justified? J Clin Endocrinol Metab 84: 756-760.
11. Miccoli P, Antonelli A, Iacconi P, Alberti B, Gambuzza C, Baschieri L (1993) Prospective, randomized, double-blind study about effectiveness of levothyroxine suppressive therapy in prevention of recurrence after operation: results at the third year of follow-up. Surgery 114: 1097-1102.
12. Kologlu S, Baskal N, Kologlu LB (1988) The value of L-thyroxine in the suppressive therapy of euthyroid nodules and in the prevention of the post-thyroidectomy recurrences. J Clin Endocrinol 26: 89-98.
13. Spira O, Birkenfeld A, Gross J, Gordon A (1979) TSH synthesis and release in the thyroidectomised rat: effect of short- and long-term hypothyroidism. Acta Endocrinol 92: 489-501.
14. Young HB, McLeod N (1972) The fate and function of the thyroid remnant. Br J Surg 59: 726-731.
15. Piraneo S, Vitri P, Galimberti A, Salvaggio A, Bastagli A (1997) Ultrasonographic surveillance after surgery for euthyroid goiter in patients treated or not with thyroxine. Eur J Surg 163: 21-26.